Skip to content

News

The Overview: July 2020

The Overview: July 2020

There’s so much happening at OCRA – from groundbreaking research to advocacy work, patient support to fundraising efforts. Starting this summer, we will share periodic highlights so that you can stay up to date on the latest. Research A pandemic won’t stop us from our mission to cure ovarian cancer. OCRA is now accepting applications for 2021 … Continued

Taking Statins Linked to Lower Mortality in Ovarian Cancer Patients

Taking Statins Linked to Lower Mortality in Ovarian Cancer Patients

(July 7, 2020) Presented as part of the American Association for Cancer Research (AACR) Virtual Annual Meeting, Dr. Kala Visvanathan and colleagues at Johns Hopkins found that statins “were associated with reduced mortality in patients with ovarian cancer.” Statins are commonly prescribed as a treatment for high cholesterol. Participants in this study who used statins … Continued

Finding Sparks, Fueling Motivation | Meet a Scientist

Finding Sparks, Fueling Motivation | Meet a Scientist

Hui Shen, PhD, spoke of a particular moment that helped cement her commitment to ovarian cancer research. She was working on a complicated project that required a new genomics technology to work. So she and her team enlisted help from an expert.  “This technologist made it all happen,” Hui explained. “We were jumping up and down with the … Continued

Healthy Lifestyle Linked to Better Prognosis

Healthy Lifestyle Linked to Better Prognosis

(June 24, 2020) Published this month in the International Journal of Cancer, researchers in Australia have found that “A healthy lifestyle after diagnosis, in particular not smoking and being physically active, may help women with ovarian cancer improve their prognosis.” Over 500 women participated in the study, self-reporting smoking status, height, weight, physical activity, diet … Continued

Get the Latest Research Updates at OCRA’s 2020 Virtual National Conference

Get the Latest Research Updates at OCRA’s 2020 Virtual National Conference

Recently we announced that OCRA’s 2020 National Conference will take place virtually on September 29-October 2, 2020. We are very excited to bring you an amazing program featuring information on the latest ovarian cancer research and treatment, engaging breakout sessions, self-care and wellness support, and community-building activities, along with a few surprises too! We understand … Continued

Overcoming Obstacles, Believing in Her Work | Meet a Scientist

Overcoming Obstacles, Believing in Her Work | Meet a Scientist

Duygu Ozmadenci, PhD, grew up in a small town on the Black Sea region of Turkey, across the waters from Chernobyl. As a teenager, she read a book that told stories of generations of people living in Anatolia and the land that eventually became Turkey. The depictions of the geography and flora, the description of … Continued

OCRA Now Accepting Applications for 2021 Research Grants

OCRA Now Accepting Applications for 2021 Research Grants

(June 11, 2020) Letters of Intent (LOIs) for Ovarian Cancer Research Alliance’s 2021 scientific grant awards are now open for submission. LOIs are due by July 10, 2020. Accepting LOIs is step one of OCRA’s highly competitive grant process.  After LOIs are received, they are reviewed by our Scientific Advisory Committee (SAC), an esteemed group … Continued

Convenient Spit Test Helps Women Assess Cancer Risk From the Comfort of Their Own Home

Convenient Spit Test Helps Women Assess Cancer Risk From the Comfort of Their Own Home

First-of-its-kind clinical trial validates remote genetic counseling (New York) June 01, 2020 – Genetic testing for cancer risk can significantly improve the prevention or treatment of hereditary cancers, but studies have shown that people who might have a genetic risk often don’t get tested. A collaborative Stand Up To Cancer ‘Dream Team’ of researchers co-funded … Continued

When a Virus is a Good Thing | Meet a Scientist

When a Virus is a Good Thing | Meet a Scientist

Scared. Overwhelmed. Exhausted. Befuddled.  These are common words one might use to describe how we feel during this unprecedented time in history. But Dmitriy Zamarin, MD, PhD, adds “fascinated” to the list as he ponders the psychological and sociological implications of the Covid-19 pandemic. “This small amount of genetic material that has spread through the … Continued

Niraparib Receives FDA Approval as First-Line Maintenance Therapy for Advanced Ovarian Cancer

Niraparib Receives FDA Approval as First-Line Maintenance Therapy for Advanced Ovarian Cancer

(May 4, 2020) On April 29th, the Food and Drug Administration approved niraparib (Zejula, GlaxoSmithKline) as a first-line maintenance treatment for advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer, regardless of BRCA mutation status. Niraparib was first approved by the FDA for treatment of recurrent ovarian cancer in 2017. This most recent approval means … Continued

SGO 2020 Highlights

SGO 2020 Highlights

(April 17, 2020) The Society of Gynecologic Oncology’s Annual Meeting on Women’s Cancer brings together women’s healthcare professionals from across the globe to discuss the latest findings in gynecologic oncology.  This year, the conference is being held virtually, through a series of high-level webinars that are free and open to the public. Click through to register … Continued

COVID-19 and Oncology Clinical Trials: An Update

COVID-19 and Oncology Clinical Trials: An Update

(April 15) The novel coronavirus, COVID-19, has become nearly all consuming. It’s impossible to turn on the news, browse social media, or walk outside without being reminded of the new, albeit temporary, state of the world. In an effort to control, slow, and hopefully stop the spread of COVID-19, drastic public health measures have been … Continued

Stay Informed

Get email updates about research news, action alerts, and ways to join the fight.

We care about your data. Read our privacy policy.